↓ Skip to main content

Constructing narratives of heroism and villainy: a case study of Myriad's BRACAnalysis(TM) compared to Genentech's Herceptin(TM)

Overview of attention for article published in Genome Medicine, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter
7 tweeters
facebook
4 Facebook pages

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Constructing narratives of heroism and villainy: a case study of Myriad's BRACAnalysis(TM) compared to Genentech's Herceptin(TM)
Published in
Genome Medicine, January 2013
DOI 10.1186/gm412
Pubmed ID
Authors

Baldwin AL, Cook-Deegan R

Abstract

The development of Herceptin(®) is welcomed as a major advance in breast cancer treatment, while Myriad's development of BRACAnalysis(®) is a widely used diagnostic. However useful and successful this product is, its presence in the public eye is tainted by predominantly negative press about gene patenting and business practices.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 32 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 21%
Student > Bachelor 6 18%
Researcher 6 18%
Other 4 12%
Student > Ph. D. Student 3 9%
Other 3 9%
Unknown 4 12%
Readers by discipline Count As %
Medicine and Dentistry 9 27%
Agricultural and Biological Sciences 5 15%
Social Sciences 5 15%
Biochemistry, Genetics and Molecular Biology 2 6%
Engineering 2 6%
Other 5 15%
Unknown 5 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2014.
All research outputs
#4,819,082
of 20,021,686 outputs
Outputs from Genome Medicine
#847
of 1,300 outputs
Outputs of similar age
#56,873
of 269,216 outputs
Outputs of similar age from Genome Medicine
#41
of 49 outputs
Altmetric has tracked 20,021,686 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,300 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.6. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,216 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.